The trajectory of companies tied to Viagra's legacy presents a challenging investment scenario . While the initial success generated substantial profits , generic copies have significantly impacted market share . Investing in related pharmaceutical businesses now requires a careful assessment of patent rights , evolving patient trends , and the pot